Drugmaker Settles Qui Tam Suit for $7.3 Million

, The Legal Intelligencer


The maker of the intravenous antifungal medication Mycamine has settled a whistleblower action against it with the U.S. government and several states for $7.3 million.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202651394128

Thank you!

This article's comments will be reviewed.